VQ-101 is the first small molecule to demonstrate >70% activation of the lysosomal enzyme glucocerebrosidase (GCase) in GBA-Parkinson’s ...

Unlock the 'Early Years Dividend' by prioritizing a child's critical first three years. Learn how strengthening ICDS and home ...

Renesas’ RA8T2 motor control MCUs address real-time control in high-end factory automation and robotics applications.

Bial, an innovation-driven biopharmaceutical company focused on neurosciences and rare diseases, today announced a significant milestone in its ongoing Phase 2 clinical study, ACTIVATE (clinicaltrials ...

Leap Motor has officially entered the 'Million Club,' completing the leap from 500,000 to one million vehicles in just 343 days, showcasing a typical 'accelerated growth curve.' This speed is far ...

On September 28, Zhu Jiangming, the founder of Leap Motor, positively responded on his personal social media platform to the ...

The new MCUs are supported in Renesas’ Flexible Motor Control development kit that enables easy evaluation of motor control ...

Detailed price information for Tonix Pharm Holdings (TNXP-Q) from The Globe and Mail including charting and trades.

Collin County is home to some of the country’s fastest-growing cities, leading North Texas’ population surge. Can local ...

Topline results from the EXPLORE-OSA trial are anticipated in 1Q 2026 ~RADNOR, Pa., Sept (GLOBE NEWSWIRE) -- Mineralys ...

The Navy’s signature system fuses the best missile technology available into a modern weapon. And because it offers navies more flexibility in limited ship space, it’s enabling the U.S. and its allies ...

Phase 2 randomized, double-blind, placebo-controlled trial planned to evaluate TNX-2900 in children and adolescents (ages 8 to 17.5 years) with Prader-Willi Syndrome under a cleared IND TNX-2900 grant ...